专利检索 ap:("Elfi Biedermann" OR "Max Hasmann" OR "Roland Löser" OR "Benno Rattel" OR "Friedemann Reiter" OR "Barbara Schein" OR "Isabel Schemainda" OR "Klaus Seibel" OR "Klaus Vogt" OR "Katja Wosikowski") AND inv:"Max Hasmann" 第 3 页

21.

发明申请
TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY 审中-公开
标题翻译：肿瘤治疗与抗VEGF抗体

公开(公告)号：US20080050385A1

公开(公告)日：2008-02-28

申请号：US11840279

申请日：2007-08-17

申请人： Thomas Friess , Max Hasmann , Werner Scheuer

发明人： Thomas Friess , Max Hasmann , Werner Scheuer

IPC分类号： A61K39/395 , A61P35/00 , A61P35/04

CPC分类号： C07K16/22 , A61K39/3955 , A61K2039/505 , A61K2039/545 , C07K2317/76 , C07K2317/92

摘要： The present invention provides a method of treating a patient suffering from relapsed HER2 positive cancer with an anti-VEGF antibody during or after treatment with an anti-HER2 antibody. The invention also provides a kit comprising an anti-VEGF antibody.

摘要翻译： 本发明提供了在用抗HER2抗体治疗期间或之后用抗VEGF抗体治疗患有复发性HER2阳性癌症的患者的方法。本发明还提供了包含抗VEGF抗体的试剂盒。

22.

发明申请
Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 审中-公开
标题翻译：用血管内皮生长因子抗体和2型人类上皮生长因子受体的抗体进行肿瘤治疗

公开(公告)号：US20070224203A1

公开(公告)日：2007-09-27

申请号：US11725777

申请日：2007-03-20

申请人： Thomas Friess , Max Hasmann , Werner Scheuer

发明人： Thomas Friess , Max Hasmann , Werner Scheuer

IPC分类号： A61K39/395

CPC分类号： A61K39/39558 , A61K39/3955 , A61K2039/507 , C07K16/22 , C07K16/3015 , C07K16/32 , C07K2317/24

摘要： The present invention provides a method of treating a breast cancer disease in a patient who has failed prior treatment with an anti-VEGF antibody, comprising administering to the patient a therapeutically effective amount of an anti-HER2 antibody while continuing said anti-VEGF antibody therapy. The invention also provides corresponding pharmaceutical kits and pharmaceutical compositions.

摘要翻译： 本发明提供了一种治疗患有先前用抗VEGF抗体治疗失败的患者的乳腺癌疾病的方法，其包括向患者施用治疗有效量的抗HER2抗体，同时继续进行所述抗VEGF抗体治疗。本发明还提供相应的药物试剂盒和药物组合物。